Department of Health and Social Care

We support ministers in leading the nation’s health and social care to help people live more independent, healthier lives for longer.



Secretary of State

 Portrait

Sajid Javid
Secretary of State for Health and Social Care

Shadow Ministers / Spokeperson
Scottish National Party
Martyn Day (SNP - Linlithgow and East Falkirk)
Shadow SNP Spokesperson (Public Health and Primary Care)

Democratic Unionist Party
Jim Shannon (DUP - Strangford)
Shadow DUP Spokesperson (Health)

Labour
Wes Streeting (LAB - Ilford North)
Shadow Secretary of State for Health and Social Care

Liberal Democrat
Munira Wilson (LDEM - Twickenham)
Liberal Democrat Spokesperson (Health and Social Care)

Labour
Baroness Wheeler (LAB - Life peer)
Shadow Spokesperson (Health and Social Care)

Scottish National Party
Philippa Whitford (SNP - Central Ayrshire)
Shadow SNP Spokesperson (Health and Social Care)

Labour
Baroness Merron (LAB - Life peer)
Shadow Spokesperson (Health and Social Care)

Plaid Cymru
Ben Lake (PC - Ceredigion)
Shadow PC Spokesperson (Health and Social Care)

Liberal Democrat
Baroness Brinton (LDEM - Life peer)
Liberal Democrat Lords Spokesperson (Health)

Scottish National Party
Lisa Cameron (SNP - East Kilbride, Strathaven and Lesmahagow)
Shadow SNP Spokesperson (Mental Health)

Labour
Baroness Thornton (LAB - Life peer)
Shadow Spokesperson (Health)
Junior Shadow Ministers / Deputy Spokesperson
Labour
Rosena Allin-Khan (LAB - Tooting)
Shadow Minister (Mental Health)
Liz Kendall (LAB - Leicester West)
Shadow Minister (Health and Social Care)
Justin Madders (LAB - Ellesmere Port and Neston)
Shadow Minister (Health and Social Care)
Alex Norris (LAB - Nottingham North)
Shadow Minister (Health and Social Care)
Ministers of State
Gillian Keegan (CON - Chichester)
Minister of State (Department of Health and Social Care)
Edward Argar (CON - Charnwood)
Minister of State (Department of Health and Social Care)
Parliamentary Under-Secretaries of State
Maggie Throup (CON - Erewash)
Parliamentary Under-Secretary (Department of Health and Social Care)
Maria Caulfield (CON - Lewes)
Parliamentary Under-Secretary (Department of Health and Social Care)
Lord Kamall (CON - Life peer)
Parliamentary Under-Secretary (Department of Health and Social Care)
Scheduled Event
Tuesday 7th December 2021
Department of Health and Social Care
Legislation - Main Chamber
Health and Care Bill – second reading
View calendar
Scheduled Event
Tuesday 7th December 2021
09:30
Health and Social Care Committee - Private Meeting - Select & Joint Committees
7 Dec 2021, 9:30 a.m.

View calendar
Debates
Tuesday 30th November 2021
Select Committee Docs
Saturday 22nd January 2022
00:00
Call for Evidence
Call For Evidence
Select Committee Inquiry
Wednesday 1st December 2021
The impact of body image on physical and mental health

MPs will examine the relationship between people’s perception of their body image and their physical and mental health. They will …

Written Answers
Wednesday 1st December 2021
Department of Health and Social Care: Boston Consulting Group
To ask the Secretary of State for Health and Social Care, if his Department will publish (a) the minutes of …
Secondary Legislation
Monday 29th November 2021
Health Protection (Coronavirus, Wearing of Face Coverings) (England) Regulations 2021
These Regulations require members of the public to wear face coverings whilst inside a relevant place specified in the Regulations, …
Bills
Tuesday 6th July 2021
Health and Care Bill 2021-22
A Bill to make provision about health and social care.
Dept. Publications
Wednesday 1st December 2021
16:35
Treaty
None available

Department of Health and Social Care Commons Appearances

Oral Answers to Questions is a regularly scheduled appearance where the Secretary of State and junior minister will answer at the Dispatch Box questions from backbench MPs

Other Commons Chamber appearances can be:
  • Urgent Questions where the Speaker has selected a question to which a Minister must reply that day
  • Adjornment Debates a 30 minute debate attended by a Minister that concludes the day in Parliament.
  • Oral Statements informing the Commons of a significant development, where backbench MP's can then question the Minister making the statement.

Westminster Hall debates are performed in response to backbench MPs or e-petitions asking for a Minister to address a detailed issue

Written Statements are made when a current event is not sufficiently significant to require an Oral Statement, but the House is required to be informed.

Most Recent Commons Appearances by Category
Nov. 23
Oral Questions
Nov. 30
Written Statements
Nov. 29
Westminster Hall
Nov. 30
Adjournment Debate
View All Department of Health and Social Care Commons Contibutions

Bills currently before Parliament

Department of Health and Social Care does not have Bills currently before Parliament


Acts of Parliament created in the 2019 Parliament


A Bill to confer power to amend or supplement the law relating to human medicines, veterinary medicines and medical devices; make provision about the enforcement of regulations, and the protection of health and safety, in relation to medical devices; and for connected purposes.

This Bill received Royal Assent on Thursday 11th February 2021 and was enacted into law.


A Bill to make provision in connection with coronavirus; and for connected purposes.

This Bill received Royal Assent on Wednesday 25th March 2020 and was enacted into law.


To make provision regarding the funding of the health service in England in respect of each financial year until the financial year that ends with 31 March 2024.

This Bill received Royal Assent on Monday 16th March 2020 and was enacted into law.

Department of Health and Social Care - Secondary Legislation

These Regulations amend the Health Protection (Coronavirus, Restrictions) (Self-Isolation) (England) Regulations 2020 to provide that:
These Regulations require members of the public to wear face coverings whilst inside a relevant place specified in the Regulations, or whilst using public transport (such as buses, trains, the London Underground, trams, aircraft and water taxis) in England, to protect against the risks to public health arising from coronavirus, except in certain limited cases. They also require businesses in places where wearing a face covering is required to display notices giving information about that requirement, and prohibit persons carrying on business in specified locations from preventing anyone from wearing a face covering, except in limited circumstances.
View All Department of Health and Social Care Secondary Legislation

Petitions

e-Petitions are administered by Parliament and allow members of the public to express support for a particular issue.

If an e-petition reaches 10,000 signatures the Government will issue a written response.

If an e-petition reaches 100,000 signatures the petition becomes eligible for a Parliamentary debate (usually Monday 4.30pm in Westminster Hall).

Trending Petitions
Petition Open
38,350 Signatures
(2,790 in the last 7 days)
Petition Open
124,849 Signatures
(2,700 in the last 7 days)
Petition Open
17,187 Signatures
(2,236 in the last 7 days)
Petition Open
1,333 Signatures
(1,240 in the last 7 days)
Petitions with most signatures
Petition Debates Contributed

Advice from the JCVI on the priority groups for a Covid-19 vaccine does not include school/childcare workers. This petition calls for these workers, who cannot distance or use PPE, to be kept safe at work by being put on the vaccine priority list when such a list is adopted into government policy.

375,209
Petition Closed
20 Jul 2021
closed 4 months, 2 weeks ago

We want the Government to commit to not rolling out any e-vaccination status/immunity passport to the British public. Such passports could be used to restrict the rights of people who have refused a Covid-19 vaccine, which would be unacceptable.

I want the Government to prevent any restrictions being placed on those who refuse to have any potential Covid-19 vaccine. This includes restrictions on travel, social events, such as concerts or sports. No restrictions whatsoever.

View All Department of Health and Social Care Petitions

Departmental Select Committee

Health and Social Care Committee

Commons Select Committees are a formally established cross-party group of backbench MPs tasked with holding a Government department to account.

At any time there will be number of ongoing investigations into the work of the Department, or issues which fall within the oversight of the Department. Witnesses can be summoned from within the Government and outside to assist in these inquiries.

Select Committee findings are reported to the Commons, printed, and published on the Parliament website. The government then usually has 60 days to reply to the committee's recommendations.


11 Members of the Health and Social Care Committee
Jeremy Hunt Portrait
Jeremy Hunt (Conservative - South West Surrey)
Health and Social Care Committee Chair since 29th January 2020
Laura Trott Portrait
Laura Trott (Conservative - Sevenoaks)
Health and Social Care Committee Member since 2nd March 2020
Dean Russell Portrait
Dean Russell (Conservative - Watford)
Health and Social Care Committee Member since 2nd March 2020
Sarah Owen Portrait
Sarah Owen (Labour - Luton North)
Health and Social Care Committee Member since 2nd March 2020
Taiwo Owatemi Portrait
Taiwo Owatemi (Labour - Coventry North West)
Health and Social Care Committee Member since 2nd March 2020
Luke Evans Portrait
Luke Evans (Conservative - Bosworth)
Health and Social Care Committee Member since 2nd March 2020
Rosie Cooper Portrait
Rosie Cooper (Labour - West Lancashire)
Health and Social Care Committee Member since 2nd March 2020
Paul Bristow Portrait
Paul Bristow (Conservative - Peterborough)
Health and Social Care Committee Member since 2nd March 2020
Barbara Keeley Portrait
Barbara Keeley (Labour - Worsley and Eccles South)
Health and Social Care Committee Member since 11th May 2020
Anum Qaisar Portrait
Anum Qaisar (Scottish National Party - Airdrie and Shotts)
Health and Social Care Committee Member since 25th May 2021
Lucy Allan Portrait
Lucy Allan (Conservative - Telford)
Health and Social Care Committee Member since 3rd November 2021
Health and Social Care Committee: Upcoming Events
Health and Social Care Committee - Private Meeting
7 Dec 2021, 9:30 a.m.
View calendar

50 most recent Written Questions

(View all written questions)
Written Questions can be tabled by MPs and Lords to request specific information information on the work, policy and activities of a Government Department

26th Nov 2021
To ask the Secretary of State for Health and Social Care, what criteria his Department plans to use to assess whether travel restrictions to a particular country are necessary to help prevent the spread of b.1.1.529 variant of covid-19.

The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.

Maggie Throup
Parliamentary Under-Secretary (Department of Health and Social Care)
26th Nov 2021
To ask the Secretary of State for Health and Social Care, if his Department will publish (a) the minutes of the phone call between the Parliamentary Under Secretary of State for Innovation and Oxford Nanopore on covid-19 testing on 4 April 2020 and (b) a list of which officials in his Department participated in the call.

The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.

Edward Argar
Minister of State (Department of Health and Social Care)
26th Nov 2021
To ask the Secretary of State for Health and Social Care, if his Department will publish (a) the minutes of the phone call between Parliamentary Under Secretary of State for Innovation, Lord O'Shaughnessy, and CEO of PUBLIC on the covid-19 test and trace programme on 10 May 2020, (b) a list of which officials or special advisers from his Department participated in that call and (c) an explanation of the capacity in which Lord O'Shaughnessy was participating.

The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.

Edward Argar
Minister of State (Department of Health and Social Care)
26th Nov 2021
To ask the Secretary of State for Health and Social Care, if his Department will publish (a) the minutes of the phone call between Parliamentary Under Secretary of State for Innovation, Lord O'Shaughnessy and Boston Consulting Group on the covid-19 test and trace programme on 8 May 2020, (b) a list of which officials or special advisers from his Department participated in that call and (c) an explanation of the capacity in which Lord O'Shaughnessy was participating.

The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.

Edward Argar
Minister of State (Department of Health and Social Care)
26th Nov 2021
To ask the Secretary of State for Health and Social Care, if his Department will publish (a) the minutes of the phone call between the Parliamentary Under Secretary of State for Innovation and Topham Guerin on test and trace marketing materials on 26 May 2020, (b) who attended on behalf of Topham Geurin and (c) a list of which officials in his Department participated in that call.

The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.

Edward Argar
Minister of State (Department of Health and Social Care)
24th Nov 2021
To ask the Secretary of State for Health and Social Care, what plans he has to reduce (a) mortality and (b) long term disability from stroke.

The NHS Long Term Plan committed to reduce mortality and long term disability from stroke, including enhanced diagnostic support in the community, better personalised planning and increasing access to rehabilitation. This will help prevent up to 150,000 heart attacks, strokes and dementia cases by 2029.

Due to training requirements, thrombectomies are restricted to Interventional Neuroradiologists in England. The General Medical Council (GMC) is working with the Royal College of Radiologists to develop a medical credential in interventional neuroradiology, or acute stroke, which addresses mechanical thrombectomy. The GMC and the Royal College are ensuring the credential has the right scope to meet the needs of health services across the United Kingdom.

The National Health Service is committed to increasing the delivery of mechanical thrombectomy from 1% to 10%. The latest data shows that 2.3% of patients are now receiving a thrombectomy following a stroke. In early 2022, the NHS will undertake a quality review with each of the seven regions to increase this rate.

Maria Caulfield
Parliamentary Under-Secretary (Department of Health and Social Care)
24th Nov 2021
To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of treating arterial fibrillation with an electric balloon.

NHS England and NHS Improvement advise that this is a new technology which offers an alternative for balloon-based catheter ablation for atrial fibrillation. At present, further research on a wider cohort of patients is required to provide more data and evidence for its use.

Maria Caulfield
Parliamentary Under-Secretary (Department of Health and Social Care)
23rd Nov 2021
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 23 November 2021 to Question 76637, on Ambulance Services: Standards, whether additional fall prevention work is being undertaken to reduce the number of ambulances required following preventable falls; and if he will make a statement.

NHS England and NHS Improvement developed the RightCare Falls and Fragility Fractures Pathway in collaboration with National Health Service professionals, Public Health England, National Osteoporosis Society to provide commissioners with resources to prevent falls, detect and manage osteoporosis and support patients following fragility fractures. NHS England and NHS Improvement plan to refresh this programme in partnership with the Best Musculoskeletal Pathway Improvement Programme within the next 12 months.

Edward Argar
Minister of State (Department of Health and Social Care)
23rd Nov 2021
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 23 November 2021 to Question 75126 on UN Climate Conference 2021: Government, how many Ministers in his Department travelled to COP26 by airplane.

One Departmental Minister travelled to COP26 by airplane on the outward leg of the journey and train for the return leg. Any unavoidable carbon emissions from COP26 will be offset, including those associated with travel.

Edward Argar
Minister of State (Department of Health and Social Care)
23rd Nov 2021
To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the cost to the NHS of the treatment of strokes and heart attacks in people with chronic kidney disease.

We have not made a specific assessment. Information on such costs is not collected in the format requested.

Maria Caulfield
Parliamentary Under-Secretary (Department of Health and Social Care)
26th Nov 2021
To ask the Secretary of State for Health and Social Care, whether he has plans to fund research into mitochondria cells and the effect upon them in relation to sufferers of Myalgic Encephalomyelitis and Chronic Fatigue Syndrome; and if he will make a statement.

The Department funds research through the National Institute for Health Research (NIHR). The NIHR welcomes funding applications for research into any aspect of human health, including myalgic encephalomyelitis and chronic fatigue syndrome (ME/CFS). However, it is not usual practice to ring-fence funds for particular topics or conditions. Applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money and scientific quality. We will continue to work with stakeholders to consider how best to support continued research into ME/CFS.

Maria Caulfield
Parliamentary Under-Secretary (Department of Health and Social Care)
23rd Nov 2021
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 9 November 2021 to Question 62570, on Kidney Diseases: Dialysis Machines, when his Department expects all renal centres to meet the recommendation outlined in the GiRFT report to achieve a 20 per cent minimum home dialysis rate; and what steps his Department plans to take to encourage those centres that have achieved a 20 per cent minimum home dialysis rate to increase that rate.

The Getting It Right First Time (GIRFT) speciality report on renal medicine, published September 2021, recommended that all renal centres provide a minimum of 20% of patients with dialysis services at home within 12 months.

NHS England and NHS Improvement’s Renal Services Transformation Plan (RSTP) has established 11 regional clinical networks to meet this recommendation. Of 51 renal centres, 16 units have met or exceeded this minimum level, with several centres achieving more than 30% of patients receiving dialysis at home. NHS England and NHS Improvement have asked renal networks to ensure units continue to develop home therapies and increase levels of dialysis at home. Providers, integrated care systems and regional commissioners will monitor progress via the UK Renal Registry and NHS England Renal datasets.

The GIRFT report set a deadline for all centres to establish the required staffing model by September 2022. NHS England and NHS Improvement are encouraging clinicians and centres to consider the GIRFT recommendations in their work and the individual sites will evaluate how best to implement them.

Edward Argar
Minister of State (Department of Health and Social Care)
23rd Nov 2021
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 9 November 2021 to Question 62570, on Kidney Diseases: Dialysis Machines, whether his Department plans to set a deadline for each of the renal clinical networks to implement a workforce plan to ensure the delivery of the dialysis programme as set out in the GiRFT report.

The Getting It Right First Time (GIRFT) speciality report on renal medicine, published September 2021, recommended that all renal centres provide a minimum of 20% of patients with dialysis services at home within 12 months.

NHS England and NHS Improvement’s Renal Services Transformation Plan (RSTP) has established 11 regional clinical networks to meet this recommendation. Of 51 renal centres, 16 units have met or exceeded this minimum level, with several centres achieving more than 30% of patients receiving dialysis at home. NHS England and NHS Improvement have asked renal networks to ensure units continue to develop home therapies and increase levels of dialysis at home. Providers, integrated care systems and regional commissioners will monitor progress via the UK Renal Registry and NHS England Renal datasets.

The GIRFT report set a deadline for all centres to establish the required staffing model by September 2022. NHS England and NHS Improvement are encouraging clinicians and centres to consider the GIRFT recommendations in their work and the individual sites will evaluate how best to implement them.

Edward Argar
Minister of State (Department of Health and Social Care)
20th Oct 2021
To ask the Secretary of State for Health and Social Care, what steps is he taking to help ensure vacancies in the care sector are filled in (a) Slough and (b) the South East.

On 3 November 2021, we published the Workforce Recruitment and Retention Fund on GOV.UK, which includes £349,004 for Slough and £22,676,944 for South East across 19 local authorities, to help bolster adult social care workforce capacity over winter, including filling vacancies.

Local authority grant allocations can be found at the following link: https://www.gov.uk/government/publications/workforce-capacity-fund-for-adult-social-care/annex-c-grant-allocations

Gillian Keegan
Minister of State (Department of Health and Social Care)
24th Nov 2021
To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of support services available to unpaid carers during covid-19 lockdowns.

While no formal assessment has been made, local authorities have a duty under the Care Act 2014 to provide carers an assessment of and support for their needs, where eligible. This includes a duty to promote an individual’s wellbeing and consider the impact of the role as a carer. We continue to work with carers’ organisations to assess and understand carers’ needs and how best to support them.

During the pandemic, we have provided carers with guidance on their health and wellbeing; funding to Carers UK to extend their support phoneline; funding to the Carers Trust for grants to provide support to unpaid carers experiencing loneliness during the pandemic; and we have worked with the Social Care Institute for Excellence to publish guidance on reopening day services, providing respite to unpaid carers.

In addition, we have published our Mental Health Recovery Action Plan, supported by an additional £500 million in 2021/22, to ensure we have the right support in place, including for unpaid carers. We are working with key stakeholders, including unpaid carers, to develop our plans and will publish further detail in our white paper on social care reform shortly.

Gillian Keegan
Minister of State (Department of Health and Social Care)
24th Nov 2021
To ask the Secretary of State for Health and Social Care, what risks to the mental and physical wellbeing of unpaid carers his Department has identified as a result of the covid-19 outbreak.

While no formal assessment has been made, local authorities have a duty under the Care Act 2014 to provide carers an assessment of and support for their needs, where eligible. This includes a duty to promote an individual’s wellbeing and consider the impact of the role as a carer. We continue to work with carers’ organisations to assess and understand carers’ needs and how best to support them.

During the pandemic, we have provided carers with guidance on their health and wellbeing; funding to Carers UK to extend their support phoneline; funding to the Carers Trust for grants to provide support to unpaid carers experiencing loneliness during the pandemic; and we have worked with the Social Care Institute for Excellence to publish guidance on reopening day services, providing respite to unpaid carers.

In addition, we have published our Mental Health Recovery Action Plan, supported by an additional £500 million in 2021/22, to ensure we have the right support in place, including for unpaid carers. We are working with key stakeholders, including unpaid carers, to develop our plans and will publish further detail in our white paper on social care reform shortly.

Gillian Keegan
Minister of State (Department of Health and Social Care)
15th Nov 2021
To ask Her Majesty's Government how many people who are immunocompromised or immunosuppressed have been hospitalised due to COVID-19 in England since 2 September.

The data requested is not held centrally.

Lord Kamall
Parliamentary Under-Secretary (Department of Health and Social Care)
23rd Nov 2021
To ask the Secretary of State for Health and Social Care, what plans his Department has to (a) identify and (b) publish any conflicts of interests on Integrated Care Boards.

The Health and Care Bill transfers clinical commissioning groups’ current requirements to manage conflicts of interest to integrated care boards. This includes maintaining and publishing a register of members’ interests and arrangements for the management of conflicts or potential conflicts of interest.

Edward Argar
Minister of State (Department of Health and Social Care)
22nd Oct 2021
To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the extent to which private sector hospital capacity in London is being used to create extra capacity in the NHS.

No recent assessment has been made. While national contracts were used to secure appropriate inpatient capacity and other resource in England, on 31 March 2021 these contracts came to an end. From 1 April 2021, NHS England and NHS Improvement returned to local commissioning arrangements and as such this information is not held centrally.

We have announced £2 billion this year through the Elective Recovery Fund and £8 billion in the following three years to tackle the elective backlog. This will enable National Health Service commissioners and trusts to secure the capacity required locally.

Edward Argar
Minister of State (Department of Health and Social Care)
16th Nov 2021
To ask Her Majesty's Government what steps they are taking to stop the importation of illegal e-cigarette products into the UK.

Through the introduction of the Tobacco and Related Products Regulations 2016, we have introduced e-cigarette product and safety standards, along with a duty to notify a product to be placed on the United Kingdom market to the Medicines and Healthcare products Regulatory Agency (MHRA). Non-compliant products are subject to local trading standards enforcement. The Department continues to work closely with the MHRA, Trading Standards and other regulatory enforcement agencies to ensure that products sold in the UK comply with regulations for all e-cigarette products and the non-compliant products are removed from the market. Central funding is provided to local authorities for local trading standards activity, including illicit e-cigarettes.

Lord Kamall
Parliamentary Under-Secretary (Department of Health and Social Care)
16th Nov 2021
To ask Her Majesty's Government what support they are providing to Trading Standards offices to undertake enforcement actions to ensure that illegally imported e-cigarette products are removed from the UK market.

Through the introduction of the Tobacco and Related Products Regulations 2016, we have introduced e-cigarette product and safety standards, along with a duty to notify a product to be placed on the United Kingdom market to the Medicines and Healthcare products Regulatory Agency (MHRA). Non-compliant products are subject to local trading standards enforcement. The Department continues to work closely with the MHRA, Trading Standards and other regulatory enforcement agencies to ensure that products sold in the UK comply with regulations for all e-cigarette products and the non-compliant products are removed from the market. Central funding is provided to local authorities for local trading standards activity, including illicit e-cigarettes.

Lord Kamall
Parliamentary Under-Secretary (Department of Health and Social Care)
16th Nov 2021
To ask Her Majesty's Government what assessment they have made of (1) clinical trial data showing the effectiveness of Ivermectin to treat COVID-19, and (2) the urgency of approving new treatments for COVID-19; and when they expect the Medicines and Healthcare products Regulatory Agency to come to a decision on approving Ivermectin for use in the UK.

Evidence from clinical trials of ivermectin as a treatment for COVID-19 is inconclusive at this stage. We will continue to monitor the data from clinical trials continuing worldwide, including the Government-funded PRINCIPLE trial, to expand the evidence base for ivermectin. We recognise the need to make treatments for COVID-19 available to patients once proven as safe and effective. The RAPID-C19 group was established to accelerate the process between the completion of clinical trials and patient access. Ivermectin will be considered for marketing authorisation in the United Kingdom as a treatment for COVID-19 should an application be received from a manufacturer.

Lord Kamall
Parliamentary Under-Secretary (Department of Health and Social Care)
15th Nov 2021
To ask Her Majesty's Government how many suspected prostate cancer patients in each local Cancer Alliance have undergone a multi-parametric magnetic resonance imaging scan in England in each year since 2016.

The information is not held in the format requested. While the number of scans of the prostate is collected, this does not represent the number of patients or whether the purpose of the scan was for suspected cancer.

Lord Kamall
Parliamentary Under-Secretary (Department of Health and Social Care)
17th Nov 2021
To ask Her Majesty's Government when they plan to publish the Women's Health Strategy; and what plans they have to include commitments on menstrual health conditions in that strategy.

We will publish the Women’s Health Strategy in due course. We are currently analysing the responses to the call for evidence which will inform the priorities, content and actions in the Strategy. Within the call for evidence, the online survey included questions on menstrual health.

Lord Kamall
Parliamentary Under-Secretary (Department of Health and Social Care)
16th Nov 2021
To ask Her Majesty's Government what plans they have, if any, to test people with immunodeficiencies for their individual responses to COVID-19 vaccinations.

The UK Health Security Agency is working with a range of partners, such as the University College of London, to monitor the effectiveness of COVID-19 vaccinations in clinical risk groups, including those with immunosuppression. The VirusWatch study is underway to monitor antibody response following vaccination among individuals with immunosuppression.

As part of the COVID-19 Immunity National Core Study, the UK Research and Innovation OCTAVE study is examining the effectiveness of vaccines in clinically at-risk groups. This includes vaccine responses in patients with certain immunosuppressed conditions.

Lord Kamall
Parliamentary Under-Secretary (Department of Health and Social Care)
23rd Nov 2021
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to reduce the risk of conflicts of interest arising on Integrated Care Boards.

The Health and Care Bill transfers clinical commissioning groups’ current requirements to manage conflicts of interest to integrated care boards (ICBs), which includes maintaining and publishing a register of members’ interests and arrangements for the management of conflicts or potential conflicts of interest.

The ICB chair can also veto members of the board if they are unsuitable and NHS England can issue guidance to ICBs in relation to appointments. In order to manage conflicts of interest of board membership, we have also brought forward an amendment to the Bill to prevent individuals from the membership of boards where there are significant interests or views that could undermine its independence.

Edward Argar
Minister of State (Department of Health and Social Care)
22nd Oct 2021
To ask the Secretary of State for Health and Social Care, how much was spent on purchasing bed capacity in private sector hospitals for each hospital Trust in London in each of the last 18 months.

National contracts were used to secure all appropriate inpatient capacity across England, which came to an end on 31 March 2021. However, these contracts related to hospital capacity, not bed capacity. Total spend on hospital capacity and health services from private sector providers from March 2020 to March 2021 is not currently available as these contracts are undergoing a reconciliation exercise. It is expected that this will be completed by the end of 2021/22. However, information is being collated at independent provider level, rather than by specific area or region. From 1 April 2021, NHS England and NHS Improvement returned to local commissioning arrangements and as such this information is not held centrally.

Edward Argar
Minister of State (Department of Health and Social Care)
3rd Nov 2021
To ask the Secretary of State for Health and Social Care, when his Department plans to respond to the letter of 20 August 2021 from the hon. Member for West Lancashire on Lymphedema treatment, ref ZA57271.

We replied to the hon. Member on 22 November.

Edward Argar
Minister of State (Department of Health and Social Care)
15th Nov 2021
To ask Her Majesty's Government how many COVID-19 test device products have been subject to desktop reviews by the UK Health Security Agency.

As of 16 November 2021, 173 applications for COVID-19 test device products have been subject to desktop review by the UK Health Security Agency. As of 16 November, 108 suppliers have submitted information as part of the desktop review validation process. However, in order to be triaged for desktop review, every application must submit accompanying data in the first instance regarding their product. There are currently 93 COVID-19 test device product applications which are ‘pending information’, where further information has been requested from the supplier.

Lord Kamall
Parliamentary Under-Secretary (Department of Health and Social Care)
15th Nov 2021
To ask Her Majesty's Government how many suppliers of COVID-19 tests have submitted information regarding their products for desktop reviews.

As of 16 November 2021, 173 applications for COVID-19 test device products have been subject to desktop review by the UK Health Security Agency. As of 16 November, 108 suppliers have submitted information as part of the desktop review validation process. However, in order to be triaged for desktop review, every application must submit accompanying data in the first instance regarding their product. There are currently 93 COVID-19 test device product applications which are ‘pending information’, where further information has been requested from the supplier.

Lord Kamall
Parliamentary Under-Secretary (Department of Health and Social Care)
22nd Oct 2021
To ask the Secretary of State for Health and Social Care, when he plans to respond to the letter dated 19 August 2021 from the hon. Member for West Lancashire, reference ZA57378 regarding surgery wait times.

We replied to the hon. Member on 30 November 2021.

Edward Argar
Minister of State (Department of Health and Social Care)
16th Nov 2021
To ask Her Majesty's Government, further to the Written Answer by Lord Kamall on 2 November (HL3362), what were the affected genes in the mitochondrial genome and the associated mutations in each of the 24 patients licensed as eligible for mitochondrial replacement treatment; and on what dates each corresponding application was approved by the Human Fertilisation and Embryology Authority.

The following table shows the gene affected and the mutation in the 26 patients licensed as eligible for mitochondrial donation treatment, the date each application was made and then approved by the Human Fertilisation and Embryology Authority (HFEA) Statutory Approvals Committee.

HFEA Application reference Gene affected by mutation Mutation Date received Date approved by the HFEA Statutory Approvals Committee

M0001 MT-TK Details omitted to protect patient identity 28 June 2017 31 August 2017

M0002 MT-TK Details omitted to protect patient identity 4 September 2017 26 October 2017

M0007 MT-ND1 m.3460 G>A 13 March 2018 24 May 2018

M0003 MT-TL1 Details omitted to protect patient identity 25 September 2017 26 July 2018

M0005 MT-TL1 m.3243 A>G 5 December 2017 26 July 2018

M0008 MT-TL1 m.3243 A>G 15 March 2018 26 July 2018

M0004 MT-TK Details omitted to protect patient identity 4 December 2017 30 August 2018

M0006 MT-TS1 Details omitted to protect patient identity 9 January 2018 30 August 2018

M0009 MT-TI m.4300 A>G 28 June 2018 27 September 2018

M0010 MT-TI m.4300 A>G 11 July 2018 27 September 2018

M0013 MT-ND4 m.11778 G>A 14 July 2018 25 October 2018

M0012 MT-ND1 m.3460 G>A 13 July 2018 25 October 2018

M0014 MT-ND4 m.11778 G>A 23 November 2018 31 January 2019

M0015 MT-ND4 m.11778 G>A 23 November 2018 31 January 2019

M0011 MT-ND4 m.11778 G>A 12 July 2018 29 August 2019

M0016 MT-TK m.8344 A>G 5 July 2019 26 September 2019

M0017 MT-ND4 m.11778 G>A 22 August 2019 31 October 2019

M0018 MT-TL1 Details omitted to protect patient identity 10 December 2019 26 March 2020

M0019 MT-TL1 Details omitted to protect patient identity 10 December 2019 26 March 2020

M0020 MT-TL1 Details omitted to protect patient identity 30 March 2020 25 June 2020

M0021 MT-ND1 Details omitted to protect patient identity 30 March 2020 25 June 2020

M0022 MT-ND1 Details omitted to protect patient identity 26 June 2020 24 September 2020

M0024 MT-ND4 Details omitted to protect patient identity 9 December 2020 29 July 2021

M0025 MT-ND4 Details omitted to protect patient identity 9 December 2020 29 July 2021

M0026 MT-ND4 Details omitted to protect patient identity 7 June 2021 4 October 2021

M0027 MT-ND1 Details omitted to protect patient identity 7 June 2021 4 October 2021

Source: HFEA

Lord Kamall
Parliamentary Under-Secretary (Department of Health and Social Care)
15th Nov 2021
To ask Her Majesty's Government what steps they are taking to improve the quality of lateral flow tests.

All tests are robustly assessed through laboratory validation, as precursor to procurement. To improve the quality of lateral flow tests The UK Health Security Agency (UKHSA) has recently introduced additional criteria that devices must meet to be accepted for validation. The criteria focus on improvements to the usability, sustainability and performance of lateral flow antigen tests, compared to devices currently available. In addition, the UKHSA works with suppliers to improve the sustainability and usability of lateral flow devices, such as reducing the amount of packaging.

Lord Kamall
Parliamentary Under-Secretary (Department of Health and Social Care)
22nd Nov 2021
To ask Her Majesty's Government whether they expect to publish the (1) Wade-Gery, and (2) Goldacre, reviews before the committee stage of the Health and Care Bill in the House of Lords.

The Wade-Gery Review was published on 23 November. The Goldacre Review will be published early in 2022, which is likely to be after Committee stage of the Bill in the House of Lords.

Lord Kamall
Parliamentary Under-Secretary (Department of Health and Social Care)
16th Nov 2021
To ask Her Majesty's Government why patients who are immunocompromised must (1) test positive for COVID-19, (2) have no detectable antibodies for COVID-19, and (3) have been hospitalised specifically for acute symptoms of COVID-19, in order to access Ronapreve; and what plans they have to end this health inequality between immunocompromised patients and the rest of the population.

The interim clinical policy for Ronapreve (casirivimab and imdevimab) was expanded on 4 November. The clinical policy prioritises the most vulnerable hospitalised patients for whom this treatment will provide the most benefit. Patients are eligible to be considered for Ronapreve if they are hospitalised for management of symptoms of confirmed COVID-19 and negative for COVID-19 antibodies. This is based on clinical trial evidence of efficacy in this group.

Patients are also eligible for Ronapreve if they have hospital-onset COVID-19 and are at high risk of progression to severe illness or if the virus presents a material risk of destabilising a pre-existing condition or compromising recovery. These patients do not need to be negative for COVID-19 antibodies. These conditions are for both immunocompromised and non-immunocompromised patients and reflect clinical trial evidence of efficacy and available supply.

Lord Kamall
Parliamentary Under-Secretary (Department of Health and Social Care)
16th Nov 2021
To ask Her Majesty's Government what plans they have to secure stocks of AstraZeneca's treatment AZD7442 as a prophylactic preventative therapy against COVID-19 infection.

We are unable to provide the information requested as it is commercially sensitive.

The Department published a Prior information Notice in Find a Tender Service on 5 October 2021 inviting suppliers to submit an Expression of Interest on neutralising antibody treatments they are developing for treating and preventing COVID-19. The engagement enables the Department to monitor development of all neutralising monoclonal antibodies for treatment and prevention of COVID-19.

Lord Kamall
Parliamentary Under-Secretary (Department of Health and Social Care)
15th Nov 2021
To ask Her Majesty's Government what assessment they have made of reports that ambulance call-outs have risen following home use of medical abortion pills; and what steps they are taking in response.

We are considering all evidence submitted to the Government’s public consultation on whether to make permanent the temporary measure allowing for home use of both pills for early medical abortion, including evidence from ambulance services. The consultation asked questions on whether other NHS services had been affected by the temporary measure. We will publish our response in due course.

Lord Kamall
Parliamentary Under-Secretary (Department of Health and Social Care)
16th Nov 2021
To ask Her Majesty's Government what plans they have to evaluate AZD7442 for emergency use as a preventative treatment against COVID-19; and what are the timelines for its approval.

We continue to monitor the emerging data for AstraZeneca’s long-acting antibody therapy, AZD7442. AstraZeneca are discussing potential approval for the therapy with the Medicines and Healthcare products Regulatory Agency.

We anticipate that further neutralising monoclonal antibody treatments will be submitted for evaluation for a marketing authorisation by the MHRA in the next few months. These treatments could become available for community treatment or preventative use.

Lord Kamall
Parliamentary Under-Secretary (Department of Health and Social Care)
16th Nov 2021
To ask Her Majesty's Government what plans they have to rollout Ronapreve as a prophylactic preventative treatment for COVID-19.

On 20 August 2021, the Medicines and Healthcare products Regulatory Agency (MHRA) approved Ronapreve (casirivimab and imdevimab) as the first monoclonal antibody combination product indicated for use in the prevention and treatment of acute COVID-19 infection.

The current supply of Ronapreve is limited globally, therefore the clinical policy prioritises the most vulnerable hospitalised patients for whom this treatment will provide the most benefit, which is supported by the clinical evidence. There are no current plans to make Ronapreve available for prophylaxis. We also anticipate that further neutralising monoclonal antibody treatments will be submitted for evaluation for a marketing authorisation by the MHRA in the next few months. If approved, these could become available for community treatment or prevention use.

Lord Kamall
Parliamentary Under-Secretary (Department of Health and Social Care)
25th Nov 2021
To ask the Secretary of State for Health and Social Care, with reference to the Autumn Budget and Spending Review 2021, how much and what proportion of the additional funding for training NHS staff will be directed towards the cancer workforce.

Following the outcome of the Spending Review 2021, plans for individual budgets for 2022/23 to 2024/25, including funding for training the cancer workforce, will be subject to a detailed financial planning exercise and finalised in due course.

Edward Argar
Minister of State (Department of Health and Social Care)
24th Nov 2021
To ask the Secretary of State for Health and Social Care, what his workforce plan is for rolling out thrombectomy procedures; and whether that plan includes radiologists in other fields, other than neuro-radiologists and cardiologists.

The NHS Long Term Plan committed to reduce mortality and long term disability from stroke, including enhanced diagnostic support in the community, better personalised planning and increasing access to rehabilitation. This will help prevent up to 150,000 heart attacks, strokes and dementia cases by 2029.

Due to training requirements, thrombectomies are restricted to Interventional Neuroradiologists in England. The General Medical Council (GMC) is working with the Royal College of Radiologists to develop a medical credential in interventional neuroradiology, or acute stroke, which addresses mechanical thrombectomy. The GMC and the Royal College are ensuring the credential has the right scope to meet the needs of health services across the United Kingdom.

The National Health Service is committed to increasing the delivery of mechanical thrombectomy from 1% to 10%. The latest data shows that 2.3% of patients are now receiving a thrombectomy following a stroke. In early 2022, the NHS will undertake a quality review with each of the seven regions to increase this rate.

Maria Caulfield
Parliamentary Under-Secretary (Department of Health and Social Care)
23rd Nov 2021
To ask the Secretary of State for Health and Social Care, when he plans to answer Question 60499 tabled by hon. Member for Liverpool, Walton on 21 October 2021.

I refer the hon. Member to the answer of 30 November to Question 60499.

Edward Argar
Minister of State (Department of Health and Social Care)
17th Nov 2021
To ask the Secretary of State for Health and Social Care, when his Department plans to set out a timetable for the delivery of dementia moonshot funding.

There is currently no planned date for publication of a strategy to deliver the dementia moonshot.

However, we have committed to invest £375 million in neurodegenerative disease research over the next five years to fund projects into a range of diseases, including dementia. A new dementia strategy, which will set out our plans in England for future years, including on research, will be published in 2022.

Gillian Keegan
Minister of State (Department of Health and Social Care)
27th Oct 2021
To ask the Secretary of State for Health and Social Care, what steps his Department takes to help ensure that Government funding allocated to local authorities for children's and young people's mental health services is used effectively to meet their needs; and what oversight there is for the effective use of those funds.

Local authority commissioned public health services in England are funded through a ring-fenced Public Health Grant, which has been maintained in the Chancellor’s Financial Statement.

Local authorities are best placed to make individual funding decisions based on local need. We will continue to work with the Local Government Association and professional bodies to share evidence and guidance that allows councils to make the best decisions to meet local need.

Each local authority must submit a return to the Department for Levelling Up, Housing and Communities, setting out how the Grant has been spent at the end of each financial year.

Gillian Keegan
Minister of State (Department of Health and Social Care)
27th Oct 2021
To ask the Secretary of State for Health and Social Care, what estimate he has made of the average waiting time for an autism assessment for children in (a) Coventry, (b) the West Midlands and (c) England; and what steps his Department is taking to reduce average waiting times for autism assessments in those areas.

It is not possible to reliably estimate the average waiting time for children to complete an assessment for autism in Coventry, the West Midlands and England from the data currently collected by NHS Digital. Children and young people are largely out of scope of the current data collection. Available data shows that during Quarter 4 of 2020/21, there were a total of 9,055 new referrals for suspected autism among under 18 year olds recorded in England. Of these, approximately 12% or 1,060 received a first appointment in 13 weeks or less and 4% or 360 received a first appointment between 13 and 26 weeks.

To reduce diagnosis waiting times for children and young people across England, we are investing an additional £10.5 million in 2021/22 as part of the COVID-19 Mental Health and Wellbeing Recovery Action Plan and the NHS Long Term Plan. Local systems are using this funding to improve different diagnostic pathways. In addition, through our new autism strategy, we are funding an early identification pilot in which healthcare and education staff working together to assess children who may be autistic more quickly within schools.

Gillian Keegan
Minister of State (Department of Health and Social Care)
25th Nov 2021
To ask the Secretary of State for Health and Social Care, with reference to the oral contributions of the Minister for Care and Mental Health of 17 November 2021, Official Report, Column 595, whether his Department has located minutes of the ministerial meeting of 9 April 2020 between Lord Bethell, Randox and the former Rt hon. Member for North Shropshire.

The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.

Edward Argar
Minister of State (Department of Health and Social Care)
25th Nov 2021
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 25 November 2021 to Question 79399 on Coronavirus: Protective Clothing, which four contracts for personal protective equipment referred through the high priority lane were subject to the eight stage assurance process.

The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.

Edward Argar
Minister of State (Department of Health and Social Care)
25th Nov 2021
To ask the Secretary of State for Health and Social Care, what records his Department holds on (a) meetings and (b) correspondence with the hon. Member for Chingford and Woodford Green since March 2020.

The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.

Edward Argar
Minister of State (Department of Health and Social Care)
25th Nov 2021
To ask the Secretary of State for Health and Social Care, what records his Department holds on (a) meetings and (b) correspondence with the hon. Member for the Vale of Glamorgan since March 2020.

The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.

Edward Argar
Minister of State (Department of Health and Social Care)